What collaboration opportunities does RMS offer?

RMS is open to a range of collaboration models reflecting the different ways that pharmaceutical companies, biotech organizations, and academic institutions might engage with the company’s platform and expertise.

Research partnerships and co-development agreements allow external organizations to work alongside RMS’s scientific team on shared research objectives, accessing RMS’s proprietary iPSC platform, differentiation protocols, and ILC cell technology. Strategic licensing arrangements provide partners with access to RMS’s intellectual property portfolio for use in their own research or product development programs. Scientific advisory and biotech consulting engagements draw on RMS’s expertise in stem cell biology, pancreatic cell differentiation, and translational research strategy to support partners’ internal programs.

RMS is also open to discussions about strategic acquisition and broader commercial partnerships for organizations seeking to accelerate the development and commercialization of its diabetes therapy platform. The company welcomes inquiries from across the biotechnology and pharmaceutical sectors, as well as from academic and public research institutions. To explore collaboration opportunities, prospective partners are encouraged to contact the RMS team directly.

Get in touch to discuss partnership and collaboration.